Expert Analysis

Lung Cancer

Source: CCO Independent Conference Coverage of the 2007 American Society of Clinical Oncology Annual Meeting*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Lung Cancer


Faculty:

  • David S. Ettinger, MD
  • David R. Gandara, MD
  • Corey J. Langer, MD

Moderator: Barbara J. Gitlitz, MD


CME CREDIT INFORMATION

Release Date: 08/10/07

Expiration Date: 08/09/08


Physicians: maximum of 1.5 AMA PRA Category 1 Credit(s)™

Registered Nurses: 1.4 Nursing CE credits

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the use of pharmacogenomic profiling in the selection of treatment for patients with non-small-cell lung cancer
  • Discuss the use of tyrosine kinase inhibitors in patients with advanced or recurrent non-small-cell lung cancer
  • Describe the use of cranial irradiation in the treatment of patients with small-cell lung cancer
  • Summarize recent data regarding the use of neoadjuvant chemotherapy in the treatment of patients with lung cancer

Topics covered include:

  • Prophylactic Cranial Irradiation in Patients With Extensive-Disease Small-Cell Lung Cancer
  • Pharmacogenomic Predictors of Response to Therapy
  • Chemoradiation Followed by Consolidation Therapy in Patients With Lung Cancer
  • Maintenance Gefitinib After Induction Chemoradiotherapy and Consolidation Docetaxel
  • Gefitinib vs Docetaxel in Japanese NSCLC Patients
  • Bevacizumab Added to Chemotherapy in Patients With Advanced-Stage NSCLC
  • Docetaxel Use Immediately After Chemotherapy in Lung Cancer
  • Preoperative Neoadjuvant Chemotherapy in Patients With Stage I-III NSCLC
  • Platinum-Based Combination Therapy in Extensive-Disease Small-Cell Lung Cancer
  • Cetuximab Plus Chemotherapy as First-Line Therapy in Advanced-Stage NSCLC
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.